BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6232315)

  • 1. Human suppressor cell induction in vitro: preferential activation by class I MHC antigen.
    Goeken NE
    J Immunol; 1984 May; 132(5):2291-9. PubMed ID: 6232315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens.
    Engleman EG; Benike CJ; Grumet FC; Evans RL
    J Immunol; 1981 Nov; 127(5):2124-9. PubMed ID: 6457863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory role of a monomorphic determinant of HLA Class I antigens in T cell proliferation.
    Turco MC; De Felice M; Corbo L; Morrone G; Mertelsmann R; Ferrone S; Venuta S
    J Immunol; 1985 Oct; 135(4):2268-73. PubMed ID: 2411790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMLR and MLR stimulating activity of human T lymphocytes activated in vitro by soluble HLA-DR antigens.
    Vanoli M; Scorza Smeraldi R; Fabio G; Bonara P; Sabbadini MG; Zanussi C
    Clin Exp Immunol; 1986 Jan; 63(1):163-70. PubMed ID: 2420496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of HLA class I- and class II-specific monoclonal antibodies on DR-restricted lymphoproliferative responses. I. Unseparated populations of effector cells.
    Sterkers G; Henin Y; Kalil J; Bagot M; Levy JP
    J Immunol; 1983 Dec; 131(6):2735-40. PubMed ID: 6227663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MLC-specific suppressor T lymphocytes in man. I. Their induction in vitro by soluble HLA-DR antigens.
    Smeraldi RS; Fabio G; Bonara P; Villa MG; Vanoli M; Pettenati C; Rugarli C; Zanussi C
    J Immunol; 1982 Mar; 128(3):1394-8. PubMed ID: 6173435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capacity of B cells to function as stimulators of a primary mixed leukocyte reaction.
    Krieger JI; Chesnut RW; Grey HM
    J Immunol; 1986 Nov; 137(10):3117-23. PubMed ID: 2945857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of antigen-specific suppressor T lymphocytes in man involves dual recognition of self class I MHC molecules and Leu-4/T3-associated structures on the surface of inducer T lymphocytes.
    Damle NK; Mohagheghpour N; Engleman EG
    J Immunol; 1984 Sep; 133(3):1235-40. PubMed ID: 6205073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse T lymphocytes proliferative responses specific for human MHC products in mouse anti-human xenogeneic MLR.
    Yoshizawa K; Yano A
    J Immunol; 1984 Jun; 132(6):2820-9. PubMed ID: 6202762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MLR-specific suppressor T lymphocytes in man. II. Functional and membrane characteristics of a specific MLR suppressor subpopulation.
    Fabio G; Scorza-Smeraldi R; Bonara P; Sabbadini Villa MG; Vanoli M; Calabi F; Zanussi C
    J Immunol; 1982 Dec; 129(6):2458-62. PubMed ID: 6216283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
    Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
    Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies against HLA-DR antigens acting on stimulator cells prevent OKT8+ T lymphocytes from acquiring sensitivity to interleukin 2 and expressing suppressor function.
    Palacios R; Guy K; Van Heyningen V
    Eur J Immunol; 1983 Jan; 13(1):64-72. PubMed ID: 6219882
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization of human lymphocytes in vitro: genetic restriction of secondary T cell responses is dictated by the HLA-DR phenotype of antigen-presenting cells.
    Ford DM; Hamblin A; Burger DR
    J Immunol; 1982 May; 128(5):2170-6. PubMed ID: 6977584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR.
    Gonwa TA; Picker LJ; Raff HV; Goyert SM; Silver J; Stobo JD
    J Immunol; 1983 Feb; 130(2):706-11. PubMed ID: 6184401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced alloreactive T-cell activation after alcohol intake is due to impaired monocyte accessory cell function and correlates with elevated IL-10, IL-13, and decreased IFNgamma levels.
    Szabo G; Mandrekar P; Dolganiuc A; Catalano D; Kodys K
    Alcohol Clin Exp Res; 2001 Dec; 25(12):1766-72. PubMed ID: 11781510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
    Dennig D; Yan Y; Ferguson K; O'Reilly RJ
    Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontogeny of the MHC antigens on human trophoblast cells during the first trimester of pregnancy.
    Montgomery B; Lala PK
    J Immunol; 1983 Nov; 131(5):2348-55. PubMed ID: 6415163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
    Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
    J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.